Imunon, Inc. (IMNN) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-31 15:42:06 ET
Imunon, Inc. (IMNN) Q4 2025 Earnings Call March 31, 2026 11:00 AM EDT
Company Participants
Stacy Lindborg - President, CEO & Director
Douglas V. Faller - Chief Medical Officer
Jeffrey W. Church - Principal Financial Officer & Principal Accounting Officer
...
Read the full article on Seeking Alpha
For further details see:
Imunon, Inc. (IMNN) Q4 2025 Earnings Call Transcript
Imunon Inc.
NASDAQ: IMNN
IMNN Trading
5.48% G/L:
$3.08 Last:
17,621 Volume:
$2.93 Open:
IMNN Latest News
March 31, 2026 08:00:00 am
IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study
March 25, 2026 08:05:00 am
IMUNON Reports Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival with IMNN-001 in Women with Newly Diagnosed Advanced Ovarian Cancer
March 24, 2026 08:00:00 am
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
IMNN Stock Data
$11,164,462
3,034,410
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Lawrenceville
